Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WHICH injection study (Part 1)
PACTR202009758229976Completed
- Sponsor
- University of Fort Hare
- Start
- Nov 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of medroxyprogesterone acetate and norethisterone enanthate in contraception (2 arms), sponsored by University of Fort Hare. Primary endpoints: Serum 17beta estradiol and Depression (BDI-II). Started Nov 2018; status: completed.
02
Drugs
medroxyprogesterone acetatenorethisterone enanthate
03
Conditions
contraception
Beyond the preview
Go deeper on PACTR202009758229976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202009758229976.